ANALISIS ANALISIS KADAR INTERLEUKIN 6 (IL-6) PADA PASIEN HEPATITIS B DI KLINIK UTAMA MATA JEC ORBITA MAKASSAR

Authors

  • Kasmuddin Darmo Universitas Megarezky
  • Arlitha dekayana Universitas Megarezky
  • Judmainnah judmainnah Universitas Megarezky
  • Risky Nurul Fadlila RN Universitas Megarezky
  • Amira Aznawi Universitas Megarezky

DOI:

https://doi.org/10.46356/jakk.v5i2.230

Keywords:

Hepatitis B, Indicator, Interleukin 6 (IL-6), ELISA

Abstract

ABSTRACT

Hepatitis B is an inflammation of the liver caused by the hepatitis B virus. When inflammation occurs, cytokines in the body will respond or recognize the type of pathogen in the form of a virus that enters the body and Interleukin 6 (IL 6) is a cytokine secreted from tissues. body during acute or chronic infection. Interleukin 6 (IL- 6) is a proinflammatory cytokine. The purpose of this study was to analyze the levels of Interleukin 6 (IL-6) in hepatitis B patients using a descriptive analytic method. The samples used were serum samples in Hepatitis B patients as many as 20 patients who were adjusted to the inclusion and exclusion criteria using the ELISA (Enzyme Linked Immunosorbent Assay) method. The results of this study obtained that the highest interleukin 6 level was 153.67 pg/mL and the lowest interleukin 6 level was 1.37 pg/mL. Hepatitis B patients with normal interleukin 6 levels were 12 patients with a percentage of 60%, while those with high interleukin 6 levels were 8 patients with a percentage of 40%. Interleukin 6 does not cause hepatitis B but interleukin 6 and hepatitis B are related. Increased levels of interleukin 6 can be used as an indicator to predict the risk of acute hepatitis B.

Keywords: Hepatitis B, Indicator, Interleukin 6 (IL-6), ELISA

 

ABSTRAK

Hepatitis B adalah peradangan pada organ hati yang disebabkan oleh virus hepatitis B. Pada saat terjadi inflamasi, sitokin yang ada dalam tubuh akan merespon atau mengenali jenis patogen berupa virus yang masuk ke dalam tubuh dan Interleukin 6 (IL 6) adalah sitokin yang disekresikan dari jaringan tubuh ketika terjadi infeksi akut atau kronik. Interleukin 6 (IL-6) merupakan sitokin proinflamasi. Tujuan dari penetilian ini adalah untuk menganalisis kadar Interleukin 6 (IL-6) pada pasien hepatitis B dengan metode deskriptif analitik. Sampel yang digunakan yaitu sampel serum pada pasien Hepatitis B sebanyak 20 pasien yang disesuaikan dengan kriteria inklusi dan ekslusi dengan menggunakan metode ELISA (Enzyme Linked Immunosorbent Assay). Hasil dari penelitian ini diperoleh kadar interleukin 6 tertinggi yaitu sebanyak 153.67 pg/mL dan kadar interleukin 6 terendah yaitu sebanyak 1.37 pg/mL. Pasien Hepatitis B dengan kadar interleukin 6 normal sebanyak 12 pasien dengan persentasi sebanyak 60%, sedangkan dengan kadar interleukin 6 tinggi sebanyak 8 pasien dengan persentasi 40%. Interleukin 6 bukan penyebab hepatitis B tetapi interleukin 6 dan hepatitis B merupakan sesuatu yang berhubungan. Meningkatnya kadar interleukin 6 bisa dijadikan indikator untuk memprediksi resiko hepatitis B akut.

Kata Kunci : Hepatitis B, Indikator, Interleukin 6 (IL-6), ELISA

 

Downloads

Published

2023-06-30

Issue

Vol. 5 No. 2 (2023): Jurnal Analis Kesehatan Kendari (JAKK) : Vol. 5 (2) Juni 2023)

Section

Articles

License

Authors who publish on JAKK can share their research in a number of ways. JAKK does not impose an embargo on published journals, meaning that researchers can access it openly after the article is published. Researchers who have subscribed to access to articles can also share.

JAKK already uses the Open Journal System (OJS) thereby enabling the final version of all published research articles to be placed in any digital archive immediately after publication. JAKK can automatically make feeds of open access articles available to any repository that wishes to receive them.

Authors who publish with this journal agree to the following terms:
* Authors retain copyright and grant the journal right of first publication, with licensed under a Creative Commons Attribution ShareAlike 4.0 International License (CC BY-SA 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
* Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
* Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.